Target intelligence / Profile preview

RNA, 7SK small nuclear pseudogene 140 (RN7SKP140)

Target: RN7SKP140
Molecular classification: Other (Pseudogene, non-functional variant of snRNA)

Overview

RN7SK pseudogene 140 (RN7SKP140) is a genomic DNA segment in humans that resembles the RN7SK small nuclear RNA gene but is classified as a pseudogene. Pseudogenes are typically non-functional remnants of genes, generated by duplication or retrotransposition events. RN7SKP140 does not encode a functional RNA or protein, and it is not known to play a role in cell signaling, transcription regulation, or disease. Its presence is cataloged in genomic databases but it is not relevant as a therapeutic target and is not linked to any molecular or clinical function[5].

Other names: RN7SKP140RNA, 7SK small nuclear pseudogene 140GC20M021407

Mechanism of action

None (no mechanism—does not generate a product or participate in biological pathways[5])

Biological functions

None (pseudogenes do not generally have direct biological function; their functional counterpart, RN7SK, scaffolds the 7SK snRNP involved in transcriptional regulation, but the pseudogene itself does not participate in these roles[5])

Disease associations

None (not established or studied; the functional RN7SK, NOT the pseudogene, has roles in cell cycle regulation and differentiation, but pseudogenes in general rarely have direct disease links unless they gain some novel function through mutation or become regulatory RNAs[5])

Safety considerations

None (no therapeutic relevance or safety concerns noted[5])

Interacting drugs

None (no drugs known to interact; this is not a protein or RNA product capable of binding drugs[5])

Biomarkers

None (not used as a biomarker in any established clinical or research context[5])

Beyond the preview

Go deeper on RNA, 7SK small nuclear pseudogene 140 (RN7SKP140).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 140 (RN7SKP140).

Explore the full profile